Escalon Medical (ESMC) versus Its Peers Financial Contrast

Escalon Medical (OTCMKTS:ESMC) is one of 75 public companies in the “Electromedical equipment” industry, but how does it contrast to its rivals? We will compare Escalon Medical to related businesses based on the strength of its profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Insider and Institutional Ownership

46.1% of shares of all “Electromedical equipment” companies are owned by institutional investors. 1.9% of Escalon Medical shares are owned by company insiders. Comparatively, 12.1% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Escalon Medical has a beta of -0.35, meaning that its stock price is 135% less volatile than the S&P 500. Comparatively, Escalon Medical’s rivals have a beta of 13.09, meaning that their average stock price is 1,209% more volatile than the S&P 500.

Profitability

This table compares Escalon Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Escalon Medical	2.13%	30.60%	5.20%
Escalon Medical Competitors	-417.50%	-199.99%	-34.60%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Escalon Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Escalon Medical	0	0	0	0	N/A
Escalon Medical Competitors	185	706	1915	96	2.66

As a group, “Electromedical equipment” companies have a potential upside of 70.26%. Given Escalon Medical’s rivals higher probable upside, analysts plainly believe Escalon Medical has less favorable growth aspects than its rivals.

Earnings & Valuation

This table compares Escalon Medical and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Escalon Medical	$12.18 million	$460,000.00	-18,175.00
Escalon Medical Competitors	$1.01 billion	$84.64 million	-430.65

Escalon Medical’s rivals have higher revenue and earnings than Escalon Medical. Escalon Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Escalon Medical rivals beat Escalon Medical on 7 of the 10 factors compared.

Escalon Medical Company Profile

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.